medicalcondition:dizziness

  • Canada sending home families of diplomats in Cuba after cases of ’new type’ of brain injury | CBC News
    http://www.cbc.ca/news/politics/cuba-diplomats-embassy-1.4621992

    Canada is designating Cuba an “unaccompanied post” — meaning diplomats’ families will not be allowed to live with them in the country during a posting — because of new information about mysterious symptoms suffered by Canadian and U.S. diplomats and their families.

    Canadian diplomatic staff in Havana were informed of the decision Monday morning. The federal government has made arrangements to bring family members home in the coming weeks.

    Ten Canadians in Cuba have experienced symptoms — including headaches, dizziness, nausea and difficulty concentrating — according to government officials who briefed reporters in Ottawa Monday.

    #syndrome_cubain

  • Calls to poison centers about supplements up 50%, especially among kids - CNN.com
    http://edition.cnn.com/2017/07/24/health/dietary-supplements-poison-control-study/index.html

    From 2005 to 2012, the rate of calls to poison control centers about dietary supplements increased by almost 50%, and most of the exposures were in children younger than 6 years old, according to a study published Monday in the Journal of Medical Toxicology.

    The study defines dietary supplements as any product that supplements the diet, including vitamins, minerals, herbs, botanicals, homeopathic agents and amino acids, and concentrates, metabolites, constituents and extracts of these ingredients.

    The researchers used data from the National Poison Data System, to which poison control centers submit their call information. From 2000 to 2012, there were 274,998 dietary supplement exposures reported to poison control centers across the US: one call every 24 minutes, on average.

    The symptoms most associated with supplement ingestion included tachycardia, or rapid heart rate; vomiting; nausea; irritability; drowsiness and dizziness.

    Seventy percent of the dietary supplement exposures were in children younger than age 6; 99% of those were unintentional. Overall, only 4.5% of all supplement exposures resulted in serious medical outcomes, mostly in children under age 6.

    Henry Spiller, study author and director of Central Ohio Poison Control, said parents still need to be extremely cautious about leaving these products within access of children.

    Sometimes, parents don’t think of keeping dietary supplements away from their kids, because they’re not medicines prescribed by the doctor. People think of them as natural,” Spiller said. “But they need to be treated as if they were a medicine. Don’t leave them out on the counter. Keep them out of reach.

  • Cancer du sein : Quand les craintes des patientes augmentent les mauvais effets des traitements
    http://www.20minutes.fr/sante/1912171-20160823-cancer-sein-quand-craintes-patientes-augmentent-mauvais-e

    Douleurs articulaires, gain de poids et bouffées de chaleur… L’importance des effets secondaires de certains traitements du cancer du sein, notamment l’hormonothérapie dépendrait étroitement des craintes des patientes, celles redoutant le pire souffrant des effets les plus importants.

    • Le résumé dans Annals of Oncology

      Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study
      http://annonc.oxfordjournals.org/content/early/2016/08/02/annonc.mdw266

      Background This study aims to determine the role of patient expectations as potentially modifiable factor of side-effects, quality of life, and adherence to endocrine treatment of breast cancer.

      Patients and methods A 2-year prospective clinical cohort study was conducted in routine primary care with postoperative patients with hormone-receptor-positive breast cancer, scheduled to start adjuvant endocrine treatment. Structured patient-reported assessments of side-effects, side-effect expectations, quality of life, and adherence took place during the first week post-surgery and after 3 and 24 months of endocrine treatment.

      Results Of 111 enrolled patients, at 3 and 24 months, 107 and 88 patients, respectively, were assessed. After 2 years of endocrine treatment, patients reported high rates of side-effects (arthralgia: 71.3%, weight gain: 53.4%, hot flashes: 46.5%), including symptoms not directly attributable to the medication (breathing problems: 28.1%, dizziness: 25.6%). Pre-treatment expectations significantly predicted patient-reported long-term side-effects and quality of life in multivariate models controlling for relevant medical and psychological variables. Relative risk of side-effects after 2 years of endocrine treatment was higher in patients with high negative expectations at baseline than in those with low negative expectations (RR = 1.833, CI 95%, 1.032–3.256). A significant interaction confirmed this expectation effect to be particularly evident in patients with high side-effects at 3 months. Furthermore, baseline expectations were associated with adherence at 24 months (r = −0.25, P = 0.006).

      Conclusions Expectations are a genuine factor of clinical outcome from endocrine treatment for breast cancer. Negative expectations increase the risk of treatment-specific side-effects, nocebo side-effects, and non-adherence. Yet, controlled studies are needed to analyze potential causal relationships. Optimizing individual expectations might be a promising strategy to improve side-effect burden, quality of life, and adherence during longer-term drug intake.